Recombinant Von Willebrand Factor in Subjects With Severe Von Willebrand Disease Undergoing Surgery

Clinical trial NCT02283268 · COMPLETED

Trial details

NCT number: NCT02283268
Sponsor: Baxalta now part of Shire
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Von Willebrand Disease

Start date: 2015-04-01
Primary completion: 2016-07-06
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.